author-photo

Kathe Balinski

5

Papers

767

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Myeloma Resistance and is Well Tolerated in Patients with Relapse Multiple Immunomodulatory Derivative of Thalidomide CC-5013 Overcomes Drug

2013
Show All
- Source
- Cite
- Save
Citations (0)
Doxil (D), Vincristine (V), Reduced Frequency Dexamethasone (d) and Revlimid(R) (DVd-R) a Phase I/II Trial in Advanced Relapsed/Refractory Multiple Myeloma (RMM) Patients.

2004 Blood
Show All
- Source
- Cite
- Save
Citations (8)
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma.

2002 Blood
Show All
- Source
- Cite
- Save
Citations (759)